Hormone infusion tested as new pain relief after surgery
NCT ID NCT06483659
Summary
This study is testing whether an intravenous infusion of the hormone oxytocin can help reduce pain and the need for opioid painkillers after a minimally invasive hysterectomy. 152 women will be randomly assigned to receive either oxytocin or a placebo (saltwater) infusion during and after their surgery. Researchers will compare pain levels and opioid use between the two groups to see if oxytocin is an effective pain management tool.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.